ABP

Abpro Holdings, Inc Common Stock
ABP
Market cap $155M

3.01 USD

+0.59

24.38%

At close Dec 26, 4:00 PM EST

After hours

2.90

-0.11

3.65%

1 day

24.38%

5 days

102.01%

1 month

3.79%

3 months

-18.87%

6 months

-18.87%

Year to date

-18.87%

1 year

-18.87%

5 years

-18.87%

10 years

-18.87%

About: Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.

Healthcare Biological Products, Except Diagnostic Substances

–

Funds holding %

of 6,809 funds

–

Analysts bullish %